Skip to Main Content

Paper Details

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.
Leukemia
6
2020
Author NameAffiliation
Tero AittokallioInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Tero AittokallioInstitute for Cancer Research, Oslo University Hospital, University of Oslo
Krister WennerbergInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Krister WennerbergBRIC and Novo Nordisk Foundation Center for Stem Cell Biology, University of Copenhagen
Olli KallioniemiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Olli KallioniemiKarolinska Institutet
  • 1 - 6

Datasets

Release 1.2